In other clinical studies, circulating Gal-3 was higher in T2DM patients [201,202,203] and thought to be a risk factor for vascular complications, such as heart failure, nephropathy, peripheral artery disease, and other vascular complications. This evidence concerns the gene LGALS3 and Nephropathy.